vs
Natural Grocers by Vitamin Cottage, Inc.（NGVC）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
Natural Grocers by Vitamin Cottage, Inc.的季度营收约是Bio-Techne的1.1倍（$335.6M vs $295.9M），Bio-Techne净利率更高（12.8% vs 3.4%，领先9.5%），Natural Grocers by Vitamin Cottage, Inc.同比增速更快（1.6% vs -6.4%），过去两年Natural Grocers by Vitamin Cottage, Inc.的营收复合增速更高（4.4% vs 4.2%）
Natural Grocers by Vitamin Cottage, Inc.是美国本土的特色零售连锁企业，主营认证有机食品、膳食补充剂、天然个护及环保家居类产品，面向健康意识较强的消费群体，门店覆盖美国多州，执行严格品控标准，拒绝售卖含人工添加剂的商品。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
NGVC vs TECH — 直观对比
营收规模更大
NGVC
是对方的1.1倍
$295.9M
营收增速更快
NGVC
高出8.0%
-6.4%
净利率更高
TECH
高出9.5%
3.4%
两年增速更快
NGVC
近两年复合增速
4.2%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $335.6M | $295.9M |
| 净利润 | $11.3M | $38.0M |
| 毛利率 | 29.5% | 64.6% |
| 营业利润率 | 4.4% | 18.4% |
| 净利率 | 3.4% | 12.8% |
| 营收同比 | 1.6% | -6.4% |
| 净利润同比 | 14.0% | 68.3% |
| 每股收益（稀释后） | $0.49 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NGVCTECH
| Q4 25 | $335.6M | $295.9M | ||
| Q3 25 | $336.1M | — | ||
| Q2 25 | $328.7M | $317.0M | ||
| Q1 25 | $335.8M | $316.2M | ||
| Q4 24 | $330.2M | $297.0M | ||
| Q3 24 | $322.7M | $289.5M | ||
| Q2 24 | $309.1M | $306.1M | ||
| Q1 24 | $308.1M | $303.4M |
净利润NGVCTECH
| Q4 25 | $11.3M | $38.0M | ||
| Q3 25 | $11.8M | — | ||
| Q2 25 | $11.6M | $-17.7M | ||
| Q1 25 | $13.1M | $22.6M | ||
| Q4 24 | $9.9M | $34.9M | ||
| Q3 24 | $9.0M | $33.6M | ||
| Q2 24 | $9.2M | $40.6M | ||
| Q1 24 | $8.0M | $49.1M |
毛利率NGVCTECH
| Q4 25 | 29.5% | 64.6% | ||
| Q3 25 | 29.5% | — | ||
| Q2 25 | 29.9% | 62.7% | ||
| Q1 25 | 30.3% | 67.9% | ||
| Q4 24 | 29.9% | 65.3% | ||
| Q3 24 | 29.6% | 63.2% | ||
| Q2 24 | 29.2% | 66.4% | ||
| Q1 24 | 29.3% | 67.4% |
营业利润率NGVCTECH
| Q4 25 | 4.4% | 18.4% | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 4.7% | -7.5% | ||
| Q1 25 | 5.2% | 12.2% | ||
| Q4 24 | 4.0% | 16.0% | ||
| Q3 24 | 3.7% | 13.8% | ||
| Q2 24 | 4.2% | 15.0% | ||
| Q1 24 | 3.7% | 22.1% |
净利率NGVCTECH
| Q4 25 | 3.4% | 12.8% | ||
| Q3 25 | 3.5% | — | ||
| Q2 25 | 3.5% | -5.6% | ||
| Q1 25 | 3.9% | 7.1% | ||
| Q4 24 | 3.0% | 11.7% | ||
| Q3 24 | 2.8% | 11.6% | ||
| Q2 24 | 3.0% | 13.3% | ||
| Q1 24 | 2.6% | 16.2% |
每股收益（稀释后）NGVCTECH
| Q4 25 | $0.49 | $0.24 | ||
| Q3 25 | $0.51 | — | ||
| Q2 25 | $0.50 | $-0.11 | ||
| Q1 25 | $0.56 | $0.14 | ||
| Q4 24 | $0.43 | $0.22 | ||
| Q3 24 | $0.38 | $0.21 | ||
| Q2 24 | $0.40 | $0.26 | ||
| Q1 24 | $0.35 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.2M | $172.9M |
| 总债务越低越好 | — | $260.0M |
| 股东权益账面价值 | $220.0M | $2.0B |
| 总资产 | $668.6M | $2.5B |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NGVCTECH
| Q4 25 | $23.2M | $172.9M | ||
| Q3 25 | $17.1M | — | ||
| Q2 25 | $13.2M | $162.2M | ||
| Q1 25 | $21.2M | $140.7M | ||
| Q4 24 | $6.3M | $177.5M | ||
| Q3 24 | $8.9M | $187.5M | ||
| Q2 24 | $13.9M | $152.9M | ||
| Q1 24 | $11.0M | $145.3M |
总债务NGVCTECH
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
股东权益NGVCTECH
| Q4 25 | $220.0M | $2.0B | ||
| Q3 25 | $212.4M | — | ||
| Q2 25 | $202.5M | $1.9B | ||
| Q1 25 | $193.0M | $2.0B | ||
| Q4 24 | $181.9M | $2.1B | ||
| Q3 24 | $174.3M | $2.1B | ||
| Q2 24 | $167.8M | $2.1B | ||
| Q1 24 | $160.0M | $2.0B |
总资产NGVCTECH
| Q4 25 | $668.6M | $2.5B | ||
| Q3 25 | $670.5M | — | ||
| Q2 25 | $659.0M | $2.6B | ||
| Q1 25 | $664.6M | $2.6B | ||
| Q4 24 | $648.9M | $2.7B | ||
| Q3 24 | $655.5M | $2.7B | ||
| Q2 24 | $654.4M | $2.7B | ||
| Q1 24 | $656.6M | $2.7B |
负债/权益比NGVCTECH
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.1M | — |
| 自由现金流经营现金流 - 资本支出 | $11.6M | — |
| 自由现金流率自由现金流/营收 | 3.4% | — |
| 资本支出强度资本支出/营收 | 2.9% | — |
| 现金转化率经营现金流/净利润 | 1.86× | — |
| 过去12个月自由现金流最近4个季度 | $42.6M | — |
8季度趋势，按日历期对齐
经营现金流NGVCTECH
| Q4 25 | $21.1M | — | ||
| Q3 25 | $15.6M | — | ||
| Q2 25 | $2.9M | $98.2M | ||
| Q1 25 | $34.1M | $41.1M | ||
| Q4 24 | $2.7M | $84.3M | ||
| Q3 24 | $24.5M | $63.9M | ||
| Q2 24 | $12.4M | $75.5M | ||
| Q1 24 | $20.2M | $81.0M |
自由现金流NGVCTECH
| Q4 25 | $11.6M | — | ||
| Q3 25 | $7.5M | — | ||
| Q2 25 | $-4.2M | $93.3M | ||
| Q1 25 | $27.6M | $31.0M | ||
| Q4 24 | $-6.9M | $77.5M | ||
| Q3 24 | $18.0M | $54.7M | ||
| Q2 24 | $3.6M | $57.5M | ||
| Q1 24 | $9.8M | $64.5M |
自由现金流率NGVCTECH
| Q4 25 | 3.4% | — | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | -1.3% | 29.4% | ||
| Q1 25 | 8.2% | 9.8% | ||
| Q4 24 | -2.1% | 26.1% | ||
| Q3 24 | 5.6% | 18.9% | ||
| Q2 24 | 1.2% | 18.8% | ||
| Q1 24 | 3.2% | 21.3% |
资本支出强度NGVCTECH
| Q4 25 | 2.9% | — | ||
| Q3 25 | 2.4% | — | ||
| Q2 25 | 2.2% | 1.5% | ||
| Q1 25 | 1.9% | 3.2% | ||
| Q4 24 | 2.9% | 2.3% | ||
| Q3 24 | 2.0% | 3.2% | ||
| Q2 24 | 2.9% | 5.9% | ||
| Q1 24 | 3.4% | 5.4% |
现金转化率NGVCTECH
| Q4 25 | 1.86× | — | ||
| Q3 25 | 1.32× | — | ||
| Q2 25 | 0.25× | — | ||
| Q1 25 | 2.60× | 1.82× | ||
| Q4 24 | 0.27× | 2.42× | ||
| Q3 24 | 2.72× | 1.90× | ||
| Q2 24 | 1.35× | 1.86× | ||
| Q1 24 | 2.54× | 1.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NGVC
| Grocery | $243.8M | 73% |
| Dietary Supplements | $60.7M | 18% |
| Manufactured Product Other | $31.0M | 9% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
